AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 34 filers reported holding AXSOME THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $663 | +24.9% | 9,500 | +28.4% | 0.00% | +50.0% |
| Q2 2023 | $531 | -57.1% | 7,400 | -63.2% | 0.00% | 0.0% |
| Q1 2023 | $1,239 | +322.9% | 20,100 | +428.9% | 0.00% | +100.0% |
| Q4 2022 | $293 | -99.8% | 3,800 | -17.4% | 0.00% | 0.0% |
| Q4 2021 | $173,000 | -2.3% | 4,600 | -14.8% | 0.00% | 0.0% |
| Q3 2021 | $177,000 | +98.9% | 5,400 | +390.9% | 0.00% | – |
| Q4 2020 | $89,000 | -85.8% | 1,100 | -87.5% | 0.00% | -100.0% |
| Q3 2020 | $627,000 | -13.4% | 8,800 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $724,000 | +224.7% | 8,800 | +131.6% | 0.00% | +200.0% |
| Q1 2020 | $223,000 | +1492.9% | 3,800 | +5.6% | 0.00% | – |
| Q1 2017 | $14,000 | -41.7% | 3,600 | 0.0% | 0.00% | – |
| Q4 2016 | $24,000 | -14.3% | 3,600 | 0.0% | 0.00% | – |
| Q3 2016 | $28,000 | +3.7% | 3,600 | -2.7% | 0.00% | – |
| Q2 2016 | $27,000 | – | 3,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |